Heated chemo showdown: one round or three for rare belly cancer?

NCT ID NCT07328737

Recruiting now Disease control Sponsor: Beijing Tsinghua Chang Gung Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving three rounds of heated chemotherapy directly into the abdomen after surgery works better than just one round for people with pseudomyxoma peritonei, a rare cancer that spreads in the belly. About 132 adults will be randomly assigned to one or three treatments. Researchers will track survival, side effects, and quality of life over several years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hyperthermic intraperitoneal chemotherapy (HIPEC)
What this could lead to: If more cycles work better, this could establish a more effective treatment schedule for pseudomyxoma peritonei, potentially improving long-term survival.
What could go wrong: This is a mid-stage trial with 132 participants, so results may not apply to all patients. Extra chemotherapy cycles could increase side effects like infections or organ damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSEUDOMYXOMA PERITONEI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pseudomyxoma peritonei

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSEUDOMYXOMA PERITONEI

Contacts and locations

Locations

Tsinghua University affiliated Beijing Tsinghua Changgung Hospital
RECRUITING

Beijing, Changping, 102218, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.